fifty-one successive patients treated with intravenous streptokinase 1.7 +/- 0.8 ( mean +/- sd ) hours after onset of symptoms of acute myocardial infarction were evaluated during a three-month posthospital follow-up period .
C0038418
streptokinase
C0027051
myocardial infarction